Modified HAS-BLED Score and Risk of Major Bleeding in Patients Receiving Dabigatran and Rivaroxaban: A Retrospective, Case-Control Study

Author： Tsu Laura V.   Berry Andrew   Wald Erin   Ehrlich Cassandra  

Publisher： American Society of Consultant Pharmacists

ISSN： 0888-5109

Source： The Consultant Pharmacist, Vol.30, Iss.7, 2015-07, pp. : 395-402

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Medication Use and Increased Risk of Falls in Hospitalized Elderly Patients: A Retrospective, Case-Control Study

By Rhalimi Mounir  

Drugs & Aging, Vol. 26, Iss. 10, 2009-10 ,pp. : 847-852

Adis International

Access to resources Recommend Favorite

Use of Statins and the Risk of Parkinson's Disease: A Retrospective Case-Control Study in the UK

By Becker Claudia  

Drug Safety, Vol. 31, Iss. 5, 2008-01 ,pp. : 399-407

Adis International

Access to resources Recommend Favorite

Rivaroxaban demonstrates non-inferiority, halves major bleeding risk

By  

Reactions Weekly, Vol. 1, Iss. 1395, 2012-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Risk of Upper Gastrointestinal Bleeding and the Degree of Serotonin Reuptake Inhibition by Antidepressants: A Case-Control Study

By Vidal Xavier   Ibáñez Luisa   Vendrell Lourdes   Conforti Ana   Laporte Joan-Ramon  

Drug Safety, Vol. 31, Iss. 2, 2008-01 ,pp. : 159-168

Adis International

Access to resources Recommend Favorite

Use of Clarithromycin and Adverse Cardiovascular Events among Older Patients Receiving Donepezil: A Population-Based, Nested Case-Control Study

By Hutson Janine R.  

Drugs & Aging, Vol. 29, Iss. 3, 2012-03 ,pp. : 205-211

Adis International

Access to resources Recommend Favorite